GlassScriptPhysician profile
Robert M Hartman
NPI 1558360164
$15,566.87
in general payments reported to CMS, 2019-2025
40 companies · $1,650 in 2025
The $1,650 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,884 · 2020: $2,901 · 2021: $2,831 · 2022: $1,980 · 2023: $1,768 · 2024: $1,552 · 2025: $1,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,647 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,646.86 |
| Education | $324.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,487.52 | 2019-2024 | |
| Janssen Biotech, INC. | $1,276.54 | 2019-2025 | Tremfya |
| Amgen INC. | $1,250.10 | 2019-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $1,135.56 | 2022-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $1,116.41 | 2019-2023 | Siliq, Targretin |
| Regeneron Healthcare Solutions, INC. | $942.22 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $875.26 | 2019-2025 | Winlevi |
| Ucb, INC. | $784.89 | 2019-2025 | Bimzelx |
| Dermavant Sciences, INC. | $777.74 | 2022-2024 | Vtama |
| Genzyme Corporation | $689.68 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $687.58 | 2019-2025 | |
| Galderma Laboratories, L.P. | $542.61 | 2019-2025 | Nemluvio, Twyneo, Oracea |
| Pfizer INC. | $537.18 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $483.55 | 2019-2022 | |
| Lilly USA, LLC | $472.94 | 2019-2025 | Taltz, Ebglyss |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.